Sign Out
Pregnancy, Labor, Delivery, and Lactation: Avoid use of Meloxicam during pregnancy (particularly late pregnancy) because of the known effects of NSAIDs on the fetal cardiovascular system (closure of ductus arteriosus). Meloxicam crosses the placental barrier.
Meloxicam's effects on labor and delivery in pregnant women are unknown.
It is not known whether Meloxicam is excreted in human milk. Since many drugs are excreted in human milk and because of the potential for serious adverse reactions from Meloxicam in breastfeeding infants, a decision should be made whether to discontinue breastfeeding or to discontinue the drug, taking into account the importance of the drug to the mother.
